Young Shin Chung
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Young Shin Chung has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Jung-Yun Lee
Department of Obstetrics and Gynecology, Yonsei University College of Medicine, Seoul, Korea
3 shared publications - Sang Wun Kim
Department of Obstetrics and Gynecology, Women’s Cancer Center, Yonsei Cancer Center, Institute of Women’s Life Medical Science, Yonsei University College of Medicine, Seoul, Korea
3 shared publications - Sung-Hoon Kim
Department of Obstetrics and Gynecology, Asan Medical Center University of Ulsan College of Medicine Seoul Republic of Korea
3 shared publications - Yong Jae Lee
Department of Obstetrics and Gynecology, Yonsei University College of Medicine, Seoul, Korea
3 shared publications - Eun Ji Nam
Department of Obstetrics and Gynecology, Institute of Women’s Life Medical Science, Yonsei University College of Medicine, Seoul, Korea
2 shared publications - Young Tae Kim
Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea
2 shared publications
Latest Publications
- Open Access
- 1 January 2023
- Published by XMLink in Journal of Gynecologic Oncology
- Vol. 34 (2)
Role of diagnostic laparoscopy in deciding primary treatment in advanced-stage ovarian cancer
Lee YJ, et al. J Gynecol Oncol. 2022 Dec;34:e17. https://doi.org/10.3802/jgo.2023.34.e17
- 1 January 2023
- Published by XMLink in Journal of Gynecologic Oncology
- Vol. 34 (2)
Open AccessRole of diagnostic laparoscopy in deciding primary treatment in advanced-stage ovarian cancer
Lee YJ, et al. J Gynecol Oncol. 2022 Dec;34:e17. https://doi.org/10.3802/jgo.2023.34.e17
- Open Access
- 1 January 2022
- Published by XMLink in Journal of Gynecologic Oncology
- Vol. 33 (3) , e28
Prognostic value of complete metabolic response on 18F-FDG-PET/CT after three cycles of neoadjuvant chemotherapy in advanced high-grade serous ovarian cancer
Chung YS, et al. J Gynecol Oncol. 2022 Jan;33(3):e28. https://doi.org/10.3802/jgo.2022.33.e28
- 1 January 2022
- Published by XMLink in Journal of Gynecologic Oncology
- Vol. 33 (3) , e28
Open AccessPrognostic value of complete metabolic response on 18F-FDG-PET/CT after three cycles of neoadjuvant chemotherapy in advanced high-grade serous ovarian cancer
Chung YS, et al. J Gynecol Oncol. 2022 Jan;33(3):e28. https://doi.org/10.3802/jgo.2022.33.e28
- Open Access
- 30 April 2021
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 7 (18) , eabe8873
Hormone autocrination by vascularized hydrogel delivery of ovary spheroids to rescue ovarian dysfunctions
Engineered ovary mimetics enable hormone autocrination and restore ovarian functions with reduction of menopause risks.
- 30 April 2021
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 7 (18) , eabe8873
Open AccessHormone autocrination by vascularized hydrogel delivery of ovary spheroids to rescue ovarian dysfunctions
Engineered ovary mimetics enable hormone autocrination and restore ovarian functions with reduction of menopause risks.
- Open Access
- 1 January 2018
- Published by XMLink in Journal of Gynecologic Oncology
- Vol. 29 (4) , e63
Impact of increased utilization of neoadjuvant chemotherapy on survival in patients with advanced ovarian cancer: experience from a comprehensive cancer center
Lee YJ, et al. J Gynecol Oncol. 2017 Dec;29:e63. https://doi.org/10.3802/jgo.2018.29.e63
- 1 January 2018
- Published by XMLink in Journal of Gynecologic Oncology
- Vol. 29 (4) , e63
Open AccessImpact of increased utilization of neoadjuvant chemotherapy on survival in patients with advanced ovarian cancer: experience from a comprehensive cancer center
Lee YJ, et al. J Gynecol Oncol. 2017 Dec;29:e63. https://doi.org/10.3802/jgo.2018.29.e63